Index Fund Advisors Inc. Sells 100 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Index Fund Advisors Inc. lessened its stake in UnitedHealth Group Incorporated (NYSE:UNHGet Rating) by 11.3% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 787 shares of the healthcare conglomerate’s stock after selling 100 shares during the period. Index Fund Advisors Inc.’s holdings in UnitedHealth Group were worth $401,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in UNH. Stratos Wealth Advisors LLC raised its stake in UnitedHealth Group by 25.6% during the 4th quarter. Stratos Wealth Advisors LLC now owns 4,363 shares of the healthcare conglomerate’s stock worth $2,191,000 after buying an additional 889 shares during the period. Wedmont Private Capital acquired a new position in UnitedHealth Group during the 4th quarter worth approximately $1,026,000. Baldwin Brothers LLC MA raised its stake in UnitedHealth Group by 1.4% during the 4th quarter. Baldwin Brothers LLC MA now owns 2,349 shares of the healthcare conglomerate’s stock worth $1,180,000 after buying an additional 33 shares during the period. Baxter Bros Inc. raised its stake in shares of UnitedHealth Group by 4.0% in the fourth quarter. Baxter Bros Inc. now owns 1,521 shares of the healthcare conglomerate’s stock worth $764,000 after purchasing an additional 58 shares during the last quarter. Finally, O Keefe Stevens Advisory Inc. purchased a new stake in shares of UnitedHealth Group in the fourth quarter worth approximately $201,000. Hedge funds and other institutional investors own 87.48% of the company’s stock.

In other UnitedHealth Group news, Director Frederick William Mcnabb III bought 89 shares of the stock in a transaction dated Thursday, May 26th. The stock was purchased at an average cost of $504.32 per share, for a total transaction of $44,884.48. Following the completion of the acquisition, the director now owns 11,259 shares of the company’s stock, valued at $5,678,138.88. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, EVP Erin Mcsweeney sold 1,273 shares of UnitedHealth Group stock in a transaction that occurred on Thursday, June 23rd. The shares were sold at an average price of $499.00, for a total transaction of $635,227.00. Following the transaction, the executive vice president now owns 8,104 shares of the company’s stock, valued at $4,043,896. The disclosure for this sale can be found here. Insiders sold 6,273 shares of company stock worth $3,065,752 over the last three months. 0.40% of the stock is owned by insiders.

Several brokerages have weighed in on UNH. Credit Suisse Group increased their price objective on UnitedHealth Group from $564.00 to $595.00 and gave the company an “outperform” rating in a report on Monday, April 18th. Royal Bank of Canada set a $563.00 price target on UnitedHealth Group and gave the stock an “outperform” rating in a report on Monday, April 18th. Wells Fargo & Company cut their price target on UnitedHealth Group from $613.00 to $612.00 and set an “overweight” rating for the company in a report on Wednesday, May 25th. BMO Capital Markets raised their price target on UnitedHealth Group from $510.00 to $600.00 and gave the stock a “market perform” rating in a report on Tuesday, April 19th. Finally, Cowen raised their price target on UnitedHealth Group from $512.00 to $596.00 in a report on Monday, April 18th. Three analysts have rated the stock with a hold rating, nineteen have issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $555.73.

Shares of NYSE:UNH opened at $505.24 on Wednesday. The stock’s 50-day moving average price is $492.46 and its 200-day moving average price is $492.91. UnitedHealth Group Incorporated has a 12-month low of $383.12 and a 12-month high of $553.29. The stock has a market capitalization of $474.00 billion, a P/E ratio of 27.65, a price-to-earnings-growth ratio of 1.61 and a beta of 0.77. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.54.

UnitedHealth Group (NYSE:UNHGet Rating) last announced its quarterly earnings data on Thursday, April 14th. The healthcare conglomerate reported $5.49 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.40 by $0.09. The firm had revenue of $80.15 billion for the quarter, compared to analysts’ expectations of $78.77 billion. UnitedHealth Group had a return on equity of 24.74% and a net margin of 5.86%. The company’s revenue for the quarter was up 14.2% compared to the same quarter last year. During the same period last year, the firm earned $5.31 earnings per share. As a group, research analysts predict that UnitedHealth Group Incorporated will post 21.75 EPS for the current year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 28th. Investors of record on Monday, June 20th were paid a $1.65 dividend. The ex-dividend date of this dividend was Thursday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $1.45. This represents a $6.60 annualized dividend and a dividend yield of 1.31%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 36.12%.

UnitedHealth Group Company Profile (Get Rating)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services.

Featured Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHGet Rating).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.